SEC Form 4 · accession 0001209191-15-043572
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William T End
Director
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 10:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | M | 4,527 | $34.37 | A | 30,354 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $34.37 | May 14, 2015 | M | 4,527 | D | — | Feb 13, 2016 | Common Stock | 4,527 | 0 | D |
Explanation of responses
- F1Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested fully on 02/14/2010.